Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:46 PM
Ignite Modification Date:
2025-12-26 @ 10:46 PM
NCT ID:
NCT06951412
Eligibility Criteria:
Inclusion Criteria:
1. Those diagnosed with type 2 diabetes,
2. Being 18 years or older
3. Individuals who do not have any fractures in the extremities, skin diseases, past wound history, open wounds and unilateral or bilateral amputation, tendonitis in the ankle, active foot ulcer and infection.
4. Those who volunteer to participate in the study,
5. Those who do not have problems with verbal communication,
6. Those who have not been diagnosed with any psychiatric disease.
7. Those with neuropathic pain of 12 points and above according to the LANS score
8. Patients receiving duloxetine drug therapy
9. Those who are not pregnant
10. Patients without peripheral artery disease, deep vein thrombosis and gonatosis will be included in the study. -
Exclusion Criteria:
1. Those who did not agree to participate in the study
2. Those under 18 years of age
3. Individuals with no fractures in the extremities, skin diseases, past wound history, open wounds and unilateral or bilateral amputation, tendonitis in the ankle, active foot ulcers and infections.
4. Those who have problems with verbal communication
5. Those with neuropathic pain below 12 points according to the LANS score
6. Patients receiving treatment other than duloxetine drug therapy
7. Those who are pregnant
8. Those with any psychiatric disorder
9. Patients with peripheral artery disease, deep vein thrombosis and gonatosis will not be included in the study.-
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT06951412
Study Brief:
Protocol Section:
NCT06951412